Ferric Carboxymaltose Dosing for a 40 kg Anemic Female
For a 40 kg anemic female, administer ferric carboxymaltose (FCM) 750 mg diluted in 100 mL normal saline, infused over 20-30 minutes, with a second dose of 750 mg given at least 7 days later for a total cumulative dose of 1500 mg. 1, 2
Dosing Algorithm
Weight-Based Calculation
- At 40 kg body weight: The standard dosing is 15 mg/kg up to a maximum of 750 mg per single dose 2
- Calculation: 40 kg × 15 mg/kg = 600 mg, but round up to the standard 750 mg vial to avoid wastage
- Total iron deficit replacement: Typically requires 1500 mg cumulative dose administered as two separate infusions 1, 2
Infusion Protocol
First Dose (Day 0):
- Dilute 750 mg FCM in 100 mL normal saline 1
- Start infusion slowly and observe for 2-3 minutes for any acute reactions
- If no reaction occurs, complete the remaining infusion over 20-30 minutes total 1
Second Dose (Day 7 or later):
- Repeat the same protocol with 750 mg FCM
- Minimum 7-day interval between doses 2
Important Clinical Considerations
Pre-Infusion Requirements
- Confirm iron deficiency anemia with hemoglobin <12 g/dL and ferritin ≤100 ng/mL (or ferritin ≤300 ng/mL when transferrin saturation ≤30%) 2
- No test dose is required for FCM 3
- Ensure resuscitation equipment is available
Monitoring During Infusion
- Observe closely during the first few minutes for infusion reactions 1
- Minor infusion reactions occur in only 1-3% of patients 1
- If a minor reaction occurs (flushing, nausea, headache), slow or temporarily stop the infusion, then resume at a slower rate
Post-Treatment Follow-Up
- Recheck CBC and iron parameters (ferritin, transferrin saturation) at 4-8 weeks after the last infusion 1
- Expected hemoglobin rise: 2.5-3.0 g/dL with appropriate dosing 4, 5
- Ferritin should increase by approximately 200-300 ng/mL 2, 6
Critical Warnings
Hypophosphatemia Risk
FCM is uniquely associated with treatment-emergent hypophosphatemia and should be avoided in patients requiring repeat infusions 1, 7. This is a distinguishing adverse effect compared to other IV iron formulations. For patients needing ongoing iron replacement, consider ferric derisomaltose (FDI) instead 1.
Pregnancy Considerations
If this patient is pregnant (common scenario for young anemic females), FCM is safe and effective in the second and third trimesters 8, 5, 9. The same dosing applies: 15 mg/kg up to 750 mg per dose, with proven safety data showing no serious infusion reactions and significant hemoglobin improvements (mean rise 2.88 g/dL) 9.
Why This Dosing Strategy
The 2024 expert consensus guidelines emphasize that while Europe and Asia routinely use 1000 mg single infusions, the US FDA-approved protocol requires two 750 mg doses separated by at least 7 days 1. This approach:
- Minimizes wastage (750 mg vials are standard in the US) 1
- Provides adequate total iron replacement (1500 mg cumulative) 2
- Maintains safety with the approved infusion rate 1
Underdosing is a critical pitfall: Real-world data shows 88% of FCM prescriptions are subtherapeutic, with mean underdosing of 522 mg, resulting in suboptimal hemoglobin response 4. Ensure the full calculated dose is administered.